FDA 483 - The Sperm and Embryo Bank of New Jersey, Inc. - September 05, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA issued a Form 483 to The Sperm and Embryo Bank of New Jersey, Inc. in Mountainside, NJ, following an inspection of their human reproductive tissue establishment. The inspection revealed significant deficiencies related to donor screening and testing practices. Specifically, the firm failed to perform timely communicable disease testing, omitted required testing for certain cell-associated diseases, and did not properly determine and document donor eligibility.
- Inspection Date
- September 5, 2023
- Product Type
- Biologics
- Person
ID · 57778d34-688c-4011-b936-60867933a2cb